| 30 |
Weill Cornell Medicine |
Oncology |
Antibody |
Anti-ART1 Monoclonal Antibody for Improved Anticancer Immunotherapy
|
| 29 |
Stanford SPARK Program |
Oncology |
Antibody |
Enhancing Host-anti-tumor Response by Preventing Thrombin Cleavage of Osteopontin
|
| 28 |
Ramot At Tel Aviv University |
Oncology |
Peptide |
Therapeutic Targeting of CD45 by Novel Agents to Immunotherapy Non-responders Tumors
|
| 27 |
Ramot At Tel Aviv University |
Oncology |
Oncolytic Virotherapy |
EHDV-TAU, a Novel Oncolytic Virus
|
| 26 |
NIH |
Oncology |
Protein |
Chimeric Adaptor Proteins (CAPs) Containing a Linker for Activation of T Cells (LAT) and a Kinase Domain for Use in T Cell-Based Immunotherapy
|
| 25 |
FDA Technology Transfer |
Oncology |
Antibody |
Chimeric Immunotoxins Targeting IL-13Rα2 Positive Human Cancers
|
| 24 |
FDA Technology Transfer |
Oncology |
Cell therapy |
Chimeric Antigen Receptor (CAR)-T cells Targeting IL-13Rα2 Positive Human Solid Cancers
|
| 23 |
Dana-Farber |
Oncology |
Cell therapy |
LMP1 Based Approach to Producing Multi-specific CD4+ CTLs for Cancer Immunotherapy
|
| 22 |
Dana-Farber |
Oncology |
Nucleotide |
Antisense Inhibitors of Long Noncoding RNA as Treatment for Multiple Myeloma
|
| 21 |
Cancer Research Horizons |
Oncology |
Peptide |
ɑvß6-binding Peptides for Tumour Targeting and Imaging
|
| 20 |
Cancer Research Horizons |
Oncology |
Antibody Conjugated |
CLEC 14A antibody
|
| 19 |
Cancer Research Horizons |
Oncology |
Antibody |
Arginase-2 Inhibitory Antibody
|
| 18 |
Boston University |
Oncology |
Antibody |
High-performance Multiplex Drug-gated CAR Circuits
|
| 17 |
Boston University |
Oncology |
Gene therapy |
Orthogonal Inducible Cas13 Platform for Programmable RNA Regulation
|
| 16 |
Weill Cornell Medicine |
Immunology, Oncology, Ophthalmology |
Small molecule |
Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis
|
| 15 |
Weill Cornell Medicine |
Immunology, Oncology |
Protein |
Inflammasome Agonist Proteins for Vaccine and Immunotherapy
|
| 14 |
Ramot At Tel Aviv University |
Immunology, Oncology |
Cell therapy |
Therapeutic Vaccine for the Treatment of Cancer
|
| 13 |
Dana-Farber |
Immunology, Oncology |
Small molecule |
CDK8 and CDK19 Small Molecule Inhibitors and Degraders
|
| 12 |
Boston Children's Hospital |
Immunology |
Antibody |
Novel Anti-PD1 Antibodies for Inhibiting T-cell Activity
|
| 11 |
Boston University |
Gastroenterology |
Nucleotide |
mRNA Therapeutics for Acute and Chronic Liver Diseases
|
